Nanophase Technologies (NANX) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Nanophase Technologies (NANX)

NANX 1.733

-1.0%

Apr 7 5:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Stefan Gruenwald who wrote (112)	3/12/1998 5:36:00 PM
From: Rick Rappaport	Read Replies (2) of 322

Have been reading SI posts for 4 months now and just now am joining. It has been wildly informative and educational. I called Margaret Huebner the indep IR person for nanx to ask a series of questions too embarassingly elementary to pose on this board and fwiw here are the results-also posted on the motley fool (non aol) board. The Asian market is key for the slurry use of the nanocrystals because of the newer style fab plants there. Domestically the old style fab cannot utilize nanx's materials and old style rules. (Can someone explain this "old style fab vs. new style fab"?). Revenues are not expected to flow until 99 from the Asian cmp (don't know what "cmp" stands for but I think it referst to the chip cleaning slurry above). Nonetheless nanx was satisfied with analyst's $.02 est for 98 (these are her words yet other analysts have .09 and .05 for 98 so I don't know which analyst nanx was referring to when they said they could meet those expectations. They currently have 44 customers and it takes about 6 months to ramp up (personalize the crystals for that company's application) and those costs are charged back to customer. Also the Ks are non exclusive and nanx can utilize that developed material elsewhere except for a Dr. Scholls agr' which is exclusive. ("Nanoguard" currently appears on Dr. Scholls footpowders and Dr. Scholls accts for 60% of that mkt) Krause is well regarded as a marketing person and for a company this size to have 3 analysts of this stature covering it is very unusual. (I don't know whether she was just tooting her own horn here or it is a fact.) Those who come to the nanx dog and pony shows concerned that this is another idea company without the mktg ability come away with fears allayed thanks to Krause and team. Huebner says nanx is very concerned about shareholder value and her indep team is trying to do just that with analysts but no big player-like Goldman-would cover without some investment banking carrot. Bottom line seems like customers that hook up with nanx are umbilically tied as no adequate substitute (competition) exists. Looks like very little downside risk (unless imho the "we're satisfied" with projections refers to the low end only of the analysts and a downgrade occurs. Long term prospect but very bright future.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next